Pharmaceutical composition comprising crystalline...

Details Pharmaceutical composition comprising crystalline... Pharmaceutical composition comprising crystalline...

2005-05-31

2005-05-31

Barts, Samuel (Department: 1621)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Radical -xh acid, or anhydride, acid halide or salt thereof...

C514S553000, C514S646000, C562S115000, C562S114000, C562S030000, C564S394000, C564S442000

Reexamination Certificate

active

06900245

ABSTRACT:
The present invention relates to a pharmaceutical composition for treating or preventing obesity, comprising novel crystalline sibutramine methanesulfonate hemihydrate of formula (I). The crystalline sibutramine methanesulfonate hemihydrate according to the present invention has a much higher solubility in water, and enhanced stability under a high humidity/temperature condition, as compared with sibutramine hydrochloride monohydrate

REFERENCES:
patent: 5459164 (1995-10-01), Vargas
patent: 6162831 (2000-12-01), Kelly et al.
patent: 6174925 (2001-01-01), Bailey et al.
patent: 6187820 (2001-02-01), Kelly et al.
patent: 6232347 (2001-05-01), Mendel et al.
patent: 6355685 (2002-03-01), Cheetham et al.
patent: 6365631 (2002-04-01), Cheetham et al.
patent: 6376551 (2002-04-01), Mendel et al.
patent: 6376552 (2002-04-01), Mendel et al.
patent: 6376554 (2002-04-01), Cheetham et al.
patent: 2184122 (1982-11-01), None
patent: 2098302 (1987-06-01), None

Affiliated with

Also associated with

Rating

Pharmaceutical composition comprising crystalline... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical composition comprising crystalline..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition comprising crystalline... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3413104